Market Overview:
The global hepatitis D virus antibody test kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hepatitis D virus infection, rising awareness about available diagnostic tests, and technological advancements in the field of diagnostics. Based on type, the global hepatitis D virus antibody test kit market is segmented into immunoglobulinM and immunoglobulinG. ImmunoglobulinM is further sub-segmented into qualitative and quantitative tests. ImmunoglobulinG is further sub-segmented into qualitative and quantitative tests. Based on application, the global hepatitis D virus antibody test kit market is segmented into hospital and clinic settings. Geographically, the global hepatitis D virus antibody test kit market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
Product Definition:
A hepatitis D virus antibody test kit is a diagnostic tool used to detect the presence of antibodies to the hepatitis D virus in a person's blood. The test is important for diagnosing acute or chronic infections with the hepatitis D virus and for monitoring treatment responses.
ImmunoglobulinM:
ImmunoglobulinM, also known as IMG Miller is a type of immunoglobulin used in the detection of Hepatitis D Virus (HDV) antibody. It is manufactured by human plasma transfusion and has been licensed by Immuno Laboratories, Inc. The product was developed under an agreement between the National Institute for Health and Care Excellence (NICE), UK and GlaxoSmithKline plc.
ImmunoglobulinG:
Immunoglobulin G (IgG) is a type of antibody, produced by the B cells in response to antigen. The immune system uses immunoglobulins to fight off infections and diseases. In laboratory tests, IgG antibodies are often used as a diagnostic tool for various medical conditions, such as hepatitis D virus (HDV).
Application Insights:
Based on the application, the market is segmented into hospital and clinic. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a large patient base with hepatitis D, increasing prevalence of chronic liver diseases and rising awareness about early diagnosis. According to data published by WHO in 2018, around 90% of people with hepatitis are reported from developing countries while 10% are found in developed countries like U.S., Germany etc. Thus increasing incidence rate leads to high demand for diagnostic kits which eventually drives growth at Hospital level during early stages of disease progression thus leading to higher revenue generation at this level over other applications during later stages when cure is achieved through medication or treatment with antiviral drugs or transplantation procedures etc.
Regional Analysis:
North America dominated the global hepatitis D virus antibody test kit market in 2017. The presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher healthcare spending and prevalence of chronic conditions are some factors attributed to its large share. In addition, increasing initiatives by government & private organizations to raise awareness regarding the disease is also expected to drive growth over the forecast period. For instance, in June 2018, CDC published a article titled “Hepatitis D Virus (HDV) Infection in U.S.
Growth Factors:
- Increasing incidence of hepatitis D virus infection
- Growing awareness about the benefits of early diagnosis and treatment
- Rising demand for point-of-care diagnostics
- Technological advancements in hepatitis D virus antibody test kit market
- Growing number of collaborations and partnerships between diagnostic companies and research institutes
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis D Virus Antibody Test Kit Market Research Report
By Type
ImmunoglobulinM, ImmunoglobulinG
By Application
Hospital, Clinic
By Companies
Innodx, Innovita, Liferiver, Sansure, Wantai Biopharm, V
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis D Virus Antibody Test Kit Market Report Segments:
The global Hepatitis D Virus Antibody Test Kit market is segmented on the basis of:
Types
ImmunoglobulinM, ImmunoglobulinG
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Innodx
- Innovita
- Liferiver
- Sansure
- Wantai Biopharm
- V
Highlights of The Hepatitis D Virus Antibody Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ImmunoglobulinM
- ImmunoglobulinG
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis D Virus Antibody Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Hepatitis D Virus Antibody Test Kit is a laboratory test that detects the presence of antibodies to the hepatitis D virus in blood or other body fluids.
Some of the key players operating in the hepatitis d virus antibody test kit market are Innodx, Innovita, Liferiver, Sansure, Wantai Biopharm, V.
The hepatitis d virus antibody test kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis D Virus Antibody Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis D Virus Antibody Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis D Virus Antibody Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis D Virus Antibody Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis D Virus Antibody Test Kit Market Size & Forecast, 2020-2028
4.5.1 Hepatitis D Virus Antibody Test Kit Market Size and Y-o-Y Growth
4.5.2 Hepatitis D Virus Antibody Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ImmunoglobulinM
5.2.2 ImmunoglobulinG
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis D Virus Antibody Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis D Virus Antibody Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ImmunoglobulinM
9.6.2 ImmunoglobulinG
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ImmunoglobulinM
10.6.2 ImmunoglobulinG
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ImmunoglobulinM
11.6.2 ImmunoglobulinG
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ImmunoglobulinM
12.6.2 ImmunoglobulinG
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ImmunoglobulinM
13.6.2 ImmunoglobulinG
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis D Virus Antibody Test Kit Market: Competitive Dashboard
14.2 Global Hepatitis D Virus Antibody Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Innodx
14.3.2 Innovita
14.3.3 Liferiver
14.3.4 Sansure
14.3.5 Wantai Biopharm
14.3.6 V
